Home002294 • SHE
add
Shenzhen Salubris Pharmaceuticals Co Ltd
Nakaraang pagsara
¥29.86
Sakop ng araw
¥29.56 - ¥30.08
Sakop ng taon
¥23.50 - ¥38.10
Market cap
33.27B CNY
Average na Volume
4.60M
P/E ratio
54.22
Dividend yield
1.68%
Primary exchange
SHE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 958.43M | 24.15% |
Gastos sa pagpapatakbo | 512.65M | 45.09% |
Net na kita | 165.62M | 17.01% |
Net profit margin | 17.28 | -5.78% |
Kita sa bawat share | — | — |
EBITDA | 279.38M | 19.13% |
Aktuwal na % ng binabayarang buwis | 5.44% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.91B | -4.84% |
Kabuuang asset | 10.23B | 8.51% |
Kabuuang sagutin | 1.59B | 6.97% |
Kabuuang equity | 8.64B | — |
Natitirang share | 1.11B | — |
Presyo para makapag-book | 3.87 | — |
Return on assets | 4.96% | — |
Return on capital | 5.93% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 165.62M | 17.01% |
Cash mula sa mga operasyon | 320.85M | 76.79% |
Cash mula sa pag-invest | -533.90M | -36.02% |
Cash mula sa financing | 308.40M | 245.90% |
Net change in cash | 88.19M | 170.79% |
Malayang cash flow | -1.21B | -19.69% |
Tungkol
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.
Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
Itinatag
Nob 3, 1998
Website
Mga Empleyado
3,517
